OBI Pharma Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Optimer Biotechnology Inc Announces Change of General Manager
Optimer Biotechnology Inc announced the change of its General Manager from Xu Yougong, who is also the Company's Chief Executive Officer, to Huang Xiumei, the Company's Chief Operating Officer.
Latest Key Developments in Biotechnology
- Share this
- Digg this